药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Amifostine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Romidepsin.
Amifostine
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Romidepsin.
Amifostine
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Romidepsin.
Amifostine
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Romidepsin.
Amifostine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Romidepsin.
Amifostine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Romidepsin.
Amifostine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Romidepsin.
Amifostine
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Romidepsin.
Amifostine
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Romidepsin.
Amifostine
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Romidepsin.
Amifostine
Arformoterol
The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Romidepsin.
Amifostine
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Romidepsin.
Amifostine
Aripiprazole
The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Romidepsin.
Amifostine
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Romidepsin.
Amifostine
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Romidepsin.
Amifostine
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Romidepsin.
Amifostine
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Romidepsin.
Amifostine
Cilostazol
The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Romidepsin.
Amifostine
Bretylium
The risk or severity of QTc prolongation can be increased when Bretylium is combined with Romidepsin.
Amifostine
Encorafenib
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Romidepsin.